Clinical Trial Update: Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes that Phase 2 and Phase 3 studies evaluating DVS SR in fibromyalgia have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• DVS SR

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Fibromyalgia | Phase 2, Phase 3 | Status: COMPLETED